Sunnyvale, California
United States
79
2021-03-11
75
2021-03-30
These are the the leading inventors for applications assigned to PHARMACYCLICS, LLC.:
PHARMACYCLICS, LLC. based in Sunnyvale, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Crystalline forms of a Bruton's tyrosine kinase inhibitor
#2 | 2020-07-30 β Patent 10,828,259 granted on 2020-11-10Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
#3 | 2020-07-16 β Patent 10,752,634 granted on 2020-08-25Crystalline forms of a brutons tyrosine kinase inhibitor
#4 | 2020-05-28 β Patent 10,751,342 granted on 2020-08-25Use of inhibitors of Bruton's tyrosine kinase (Btk)
#5 | 2020-03-05 β Patent 10,898,461 granted on 2021-01-26Salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same
#6 | 2020-01-09 β Patent 10,695,350 granted on 2020-06-30Methods of treating and preventing graft versus host disease
#7 | 2019-11-28 β Patent 10,653,696 granted on 2020-05-19Use of inhibitors of bruton's tyrosine kinase (BTK)
#8 | 2019-04-18INHIBITORS OF BRUTON'S TYROSINE KINASE
#9 | 2019-04-04INHIBITORS OF BRUTON'S TYROSINE KINASE
#10 | 2018-12-20 β Patent 10,294,232 granted on 2019-05-21Crystalline forms of a Bruton's tyrosine kinase inhibitor
#11 | 2018-12-20 β Patent 10,294,231 granted on 2019-05-21Crystalline forms of a Bruton's tyrosine kinase inhibitor
#12 | 2018-11-15 β Patent 10,266,540 granted on 2019-04-23Crystalline forms of a Bruton's tyrosine kinase inhibitor
#13 | 2018-11-08 β Patent 10,125,140 granted on 2018-11-13Crystalline forms of a bruton's tyrosine kinase inhibitor
#14 | 2018-09-13 β Patent 10,478,439 granted on 2019-11-19Use of inhibitors of bruton's tyrosine kinase (Btk)
#15 | 2018-09-06 β Patent 10,213,386 granted on 2019-02-26Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
#16 | 2018-07-03 β Patent 10,010,507 granted on 2018-07-03Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
#17 | 2018-06-28 β Patent 10,065,968 granted on 2018-09-04Crystalline forms of a bruton's tyrosine kinase inhibitor
#18 | 2018-06-28 β Patent 10,106,548 granted on 2018-10-23Crystalline forms of a Bruton's tyrosine kinase inhibitor
#19 | 2018-06-07 β Patent 10,226,466 granted on 2019-03-12Methods of treating fibrosis
#20 | 2018-03-22 β Patent 10,463,668 granted on 2019-11-05Methods of treating and preventing graft versus host disease
#21 | 2018-03-15 β Patent 10,016,434 granted on 2018-07-10Methods for the treatment of HER2 amplified cancer
#22 | 2018-02-08 β Patent 10,016,435 granted on 2018-07-10Use of inhibitors of Bruton's tyrosine kinase (Btk)
#23 | 2018-02-01 β Patent 10,105,368 granted on 2018-10-23Formulations of a Bruton's tyrosine kinase inhibitor
#24 | 2018-01-18 β Patent 10,004,746 granted on 2018-06-26Use of inhibitors of Bruton's tyrosine kinase (Btk)
#25 | 2018-01-11SYNTHESIS OF A BRUTON?S TYROSINE KINASE INHIBITOR
#26 | 2017-11-23 β Patent 10,105,552 granted on 2018-10-23Formulations of histone deacetylase inhibitor and uses thereof
#27 | 2017-11-02 β Patent 10,150,748 granted on 2018-12-11Salt or abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them
#28 | 2017-08-10 β Patent 9,725,455 granted on 2017-08-08Crystalline forms of a bruton's tyrosine kinase inhibitor
#29 | 2017-06-01 β Patent 9,724,349 granted on 2017-08-08Methods for the treatment of HER2 amplified cancer
#30 | 2017-04-13 β Patent 9,713,617 granted on 2017-07-25Crystalline forms of a Bruton's tyrosine kinase inhibitor
#31 | 2017-02-09 β Patent 10,004,745 granted on 2018-06-26Use of inhibitors of Bruton'S tyrosine kinase (Btk)
#32 | 2016-12-08 β Patent 9,656,988 granted on 2017-05-23Inhibitors of Bruton's tyrosine kinase
#33 | 2016-11-10 β Patent 9,814,721 granted on 2017-11-14Use of inhibitors of bruton's tyrosine kinase (BTK)
#34 | 2016-09-08 β Patent 9,655,857 granted on 2017-05-23Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
#35 | 2016-07-14 β Patent 9,844,552 granted on 2017-12-19Methods of treating fibrosis
#36 | 2016-06-23 β Patent 9,801,883 granted on 2017-10-31Use of inhibitors of bruton's tyrosine kinase (Btk)
#37 | 2016-06-16 β Patent 9,637,487 granted on 2017-05-02Purinone compounds as kinase inhibitors
#38 | 2016-02-11BIOMARKERS FOR THE IDENTIFICATION OF CHEMOSENSITIVITY
#39 | 2016-02-11 β Patent 9,545,407 granted on 2017-01-17Formulations of a bruton's tyrosine kinase inhibitor
#40 | 2016-02-11 β Patent 9,730,938 granted on 2017-08-15Bruton's tyrosine kinase inhibitor combinations and uses thereof
#41 | 2016-02-04 β Patent 9,533,991 granted on 2017-01-03Inhibitors of Bruton's tyrosine kinase
#42 | 2016-01-07 β Patent 9,708,326 granted on 2017-07-18Inhibitors of bruton's tyrosine kinase
#43 | 2016-01-07 β Patent 9,580,416 granted on 2017-02-28Inhibitors of Bruton's tyrosine kinase
#44 | 2016-01-07 β Patent 9,795,605 granted on 2017-10-24Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
#45 | 2015-11-19 β Patent 9,862,722 granted on 2018-01-09Inhibitors of Bruton's tyrosine kinase
#46 | 2015-11-12 β Patent 9,186,347 granted on 2015-11-17Hydroxamates as therapeutic agents
#47 | 2015-10-22 β Patent 9,371,281 granted on 2016-06-21Indole derivatives as inhibitors of histone deacetylase
#48 | 2015-09-24 β Patent 9,885,086 granted on 2018-02-06Phospholipase C gamma 2 and resistance associated mutations
#49 | 2015-08-27 β Patent 9,540,385 granted on 2017-01-10Pyrrolopyrimidine compounds as kinase inhibitors
#50 | 2015-07-02 β Patent 10,954,567 granted on 2021-03-23Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
#51 | 2015-06-11 β Patent 9,540,382 granted on 2017-01-10Crystalline forms of a Bruton's tyrosine kinase inhibitor
#52 | 2015-06-11 β Patent 9,382,246 granted on 2016-07-05Inhibitors of Bruton's tyrosine kinase
#53 | 2015-05-14 β Patent 9,181,263 granted on 2015-11-10Inhibitors of bruton's tyrosine kinase
#54 | 2015-04-30 β Patent 9,795,604 granted on 2017-10-24Methods of treating and preventing graft versus host disease
#55 | 2015-04-23 β Patent 9,133,134 granted on 2015-09-15Inhibitors of bruton's tyrosine kinase
#56 | 2015-04-02 β Patent 9,624,224 granted on 2017-04-18Inhibitors of Bruton's tyrosine kinase
#57 | 2015-02-12 β Patent 9,415,050 granted on 2016-08-16Methods for the treatment of HER2 amplified cancer
#58 | 2015-02-05 β Patent 9,421,208 granted on 2016-08-23Methods for the treatment of solid tumors
#59 | 2015-01-15 β Patent 9,546,172 granted on 2017-01-17Pyrazolo[3,4-d]pyrimidine and pyrazolo[2,3-d]pyrimidine compounds as kinase inhibitors
#60 | 2014-12-25 β Patent 9,162,986 granted on 2015-10-202-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
#61 | 2014-12-25 β Patent 9,469,642 granted on 2016-10-18Purinone compounds as kinase inhibitors
#62 | 2014-11-20 β Patent 9,492,423 granted on 2016-11-15Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
#63 | 2014-11-13 β Patent 9,163,028 granted on 2015-10-20Inhibitors of bruton's tyrosine kinase
#64 | 2014-08-07 β Patent 9,181,280 granted on 2015-11-10Factor VIIa inhibitor
#65 | 2014-07-31 β Patent 9,156,846 granted on 2015-10-13Inhibitors of Bruton's tyrosine kinase
#66 | 2014-07-10 β Patent 9,801,881 granted on 2017-10-31Use of inhibitors of bruton's tyrosine kinase (BTK)
#67 | 2014-07-03 β Patent 9,163,026 granted on 2015-10-20Inhibitors of Bruton's tyrosine kinase
#68 | 2014-06-19 β Patent 9,181,257 granted on 2015-11-10Inhibitors of Bruton's tyrosine kinase
#69 | 2014-06-12 β Patent 9,133,198 granted on 2015-09-15Inhibitors of bruton'S tyrosine kinase
#70 | 2014-05-22 β Patent 9,409,911 granted on 2016-08-09Inhibitors of bruton's tyrosine kinase
#71 | 2014-05-15 β Patent 9,266,893 granted on 2016-02-23Inhibitors of Bruton's tyrosine kinase
#72 | 2014-05-15 β Patent 9,717,731 granted on 2017-08-01TEC family kinase inhibitor adjuvant therapy
#73 | 2014-02-27 β Patent 9,403,032 granted on 2016-08-02Formulations of histone deacetylase inhibitor and uses therof
#74 | 2013-12-19 β Patent 9,296,753 granted on 2016-03-29Crystalline forms of a Bruton's tyrosine kinase inhibitor
#75 | 2013-07-04 β Patent 9,273,051 granted on 2016-03-01Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
#76 | 2013-01-17 β Patent 9,138,436 granted on 2015-09-22Inhibitors of Bruton's tyrosine kinase
#77 | 2013-01-03 β Patent 9,278,100 granted on 2016-03-08Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
#78 | 2012-11-01 β Patent 9,139,591 granted on 2015-09-22Inhibitors of bruton's tyrosine kinase
#79 | 2008-06-26 β Patent 9,408,816 granted on 2016-08-09Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
Also check out PHARMACYCLICS LLC's (Sunnyvale, United States) applicant profile with 65 patent applications submitted.
103938 β